Board approved issuance of 7,93,650 convertible warrants at ₹315 each to P.K. Bio Link Pvt Ltd, totalling ~₹25 crore.
Authorised share capital proposed to increase from ₹13.43 crore to ₹18.43 crore by adding 50 lakh equity shares of ₹10 each.
Internal Auditor M/s Somnath Ray & Associates resigned; M/s J Kumar Jain & Associates appointed as replacement for FY 2025-26.
Both the capital increase and warrant issuance are subject to shareholder approval via postal ballot.